Skip to main content
. 2022 Jan 17;11(2):463. doi: 10.3390/jcm11020463

Table 4.

Therapeutic effects of the treatments for improvement of primary Sjögren syndrome with ocular surface inflammation.

95% CI
Treatments ß Lower Upper p
Oral pilocarpine 1.050 1.000 1.102 0.092
Low-dose oral steroid 1.250 0.875 1.745 0.278
Tear substitutes
 Carbomer gel 0.986 0.888 1.094 0.786
 Lanoline ointment 1.097 0.948 1.269 0.214
 Diquafosol 3% 1.012 0.924 1.108 0.800
Topical cyclosporine 1.084 0.980 1.199 0.098
Steroid eye drops (frequency dependent)
 Prednisolone 1% 1.477 1.292 1.688 <0.001 *
 Loteprednol 0.5% 1.390 1.076 1.798 0.012 *
 Fluorometholone 0.1% 1.245 1.149 1.350 <0.001 *
Punctal plug insertion
 Lower eyelid 2.257 1.927 2.643 <0.001 *
 Upper eyelid 1.702 1.402 2.067 0.002 *

Adjustment for corneal staining score. * p < 0.05.